Victoria J. Bartlett

Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to <i>ANGPTL3</i> mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia

Daniel Gaudet, Ewa Karwatowska‐Prokopczuk, Seth J. Baum et al. · European Heart Journal · 2020 · 277 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk

Jean‐Claude Tardif, Ewa Karwatowska‐Prokopczuk, Eric St Amour et al. · European Heart Journal · 2021 · 202 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +16

Safety Evaluation of Lipid Nanoparticle–Formulated Modified mRNA in the Sprague-Dawley Rat and Cynomolgus Monkey

Maja Sedic, Joseph J. Senn, Andy Lynn et al. · Veterinary Pathology · 2017 · 188 citations

Pharmacy, Pharmacology, Toxicology +17

Small Molecule Inhibitors of LcrF, a <i>Yersinia pseudotuberculosis</i> Transcription Factor, Attenuate Virulence and Limit Infection in a Murine Pneumonia Model

Lynne Garrity-Ryan, Oak K. Kim, Joan-Miquel Balada-Llasat et al. · Infection and Immunity · 2010 · 72 citations · Full text

Life Sciences, Infectious Diseases, Host-pathogen Interactions +16

<i>N</i>-Hydroxybenzimidazole Inhibitors of the Transcription Factor LcrF in <i>Yersinia</i>: Novel Antivirulence Agents

Oak K. Kim, Lynne Garrity-Ryan, Victoria J. Bartlett et al. · Journal of Medicinal Chemistry · 2009 · 62 citations · Full text

Medicine, Infectious Diseases, Pharmacology +8